{"gene":"APC","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1991,"finding":"The APC gene was identified at chromosome 5q21, found to be mutated in familial adenomatous polyposis (FAP) patients and in sporadic colorectal cancer; the gene encodes an unusually large protein predicted to contain coiled-coil regions.","method":"Positional cloning, SSCP mutation analysis, DNA sequencing","journal":"Cell / Science","confidence":"High","confidence_rationale":"Tier 1 — foundational cloning papers replicated across multiple independent labs simultaneously","pmids":["1651174","1651562","1651563","1678319"],"is_preprint":false},{"year":1992,"finding":"Somatic mutations in APC in colorectal tumors cluster within a small region of exon 15 (mutation cluster region, MCR), and >95% result in truncation of the APC protein; over 80% of colorectal tumors carry at least one APC mutation.","method":"DNA sequencing of tumor samples, LOH analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — large series of tumors with direct sequencing, replicated across labs","pmids":["1338904"],"is_preprint":false},{"year":1993,"finding":"APC protein associates with beta-catenin (a 95 kDa protein that binds E-cadherin) in cells, as demonstrated by co-immunoprecipitation with APC antibodies, suggesting APC is involved in cell adhesion.","method":"Co-immunoprecipitation, protein purification, peptide sequencing","journal":"Science","confidence":"High","confidence_rationale":"Tier 1/2 — reciprocal co-IP, protein identification by sequencing, replicated in same issue by independent lab","pmids":["8259518","8259519"],"is_preprint":false},{"year":1993,"finding":"APC associates with both alpha-catenin and beta-catenin via a 27-residue fragment containing a 15-amino acid repeat of APC, revealing a direct structural link between APC, the catenins, and cell adhesion machinery.","method":"Co-immunoprecipitation, peptide mapping, nucleotide sequence analysis","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — minimal binding domain mapped, replicated across two simultaneous independent studies","pmids":["8259519"],"is_preprint":false},{"year":1993,"finding":"Full-length APC (~300 kDa) is expressed in normal cells, whereas colorectal tumor cells predominantly express truncated APC proteins lacking the C-terminus; APC localizes to the cytoplasm with more intense basolateral staining in the upper portions of colonic crypts, suggesting increased expression with cell maturation.","method":"Western blot with monoclonal/polyclonal antibodies, immunohistochemistry","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — direct protein detection across 40+ cell lines with antibody panel, functional implication of localization","pmids":["8385345"],"is_preprint":false},{"year":1994,"finding":"E-cadherin and APC directly compete for binding to the internal armadillo-like repeats of beta-catenin; the NH2-terminal domain of beta-catenin then mediates cytoskeletal interaction via alpha-catenin, establishing that APC forms cell-junction-like complexes and that beta-catenin is a central regulator of both adhesion and tumor suppression.","method":"In vitro binding assays, co-immunoprecipitation, competition experiments","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — direct competition binding assay with purified proteins, mechanistic mapping of binding domains","pmids":["7806582"],"is_preprint":false},{"year":1995,"finding":"APC binds to the novel protein EB1 (a 268-amino acid protein with yeast homolog) through the carboxyl terminus of APC, as confirmed by two-hybrid screening, in vitro binding assays, and co-immunoprecipitation with anti-EB1 antibodies in vivo.","method":"Yeast two-hybrid, in vitro binding assay, co-immunoprecipitation","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1/2 — interaction confirmed by three orthogonal methods including in vivo co-IP","pmids":["7606712"],"is_preprint":false},{"year":1996,"finding":"APC binds to GSK3beta when beta-catenin is present in excess; APC is a substrate for GSK3beta in vitro and phosphorylation sites were mapped to the central region of APC; phosphorylation by GSK3beta of this central region is required for beta-catenin binding to that region, establishing APC as part of the beta-catenin destruction complex.","method":"Co-immunoprecipitation, in vitro kinase assay, phosphorylation site mapping","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with phosphorylation site mapping, reciprocal interactions confirmed","pmids":["8638126"],"is_preprint":false},{"year":1996,"finding":"Inducible expression of APC in colorectal cancer cells containing only inactive endogenous APC alleles causes substantial reduction in cell growth through induction of apoptosis, establishing a direct tumor-suppressive function for APC via programmed cell death.","method":"Inducible expression system, cell growth assay, apoptosis assay","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — direct functional rescue with defined cellular phenotype (apoptosis induction)","pmids":["8755583"],"is_preprint":false},{"year":1998,"finding":"Human Axin binds directly to beta-catenin, GSK3beta, and APC in vitro; endogenous proteins form a complex in cells; Axin binding sites on APC map to a region deleted in cancer; Axin acts as a scaffold to coordinate APC, beta-catenin and GSK3beta, and dramatically facilitates GSK3beta-dependent phosphorylation of APC and beta-catenin.","method":"In vitro binding assays, co-immunoprecipitation from cells, overexpression/phosphorylation assays","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted complex with multiple proteins, phosphorylation assay in vitro and in vivo","pmids":["9601641"],"is_preprint":false},{"year":1998,"finding":"Axin forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin; APC is integral to this complex through direct interaction with Axin's APC-binding domain.","method":"Yeast two-hybrid, in vitro binding assay, co-immunoprecipitation, in vitro kinase assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — reconstituted ternary complex and kinase assay, replicated","pmids":["9482734"],"is_preprint":false},{"year":1999,"finding":"Beta-TrCP F-box protein binds directly to phosphorylated beta-catenin (phosphorylated at GSK3beta sites) and is a component of an E3 ubiquitin ligase responsible for targeted degradation of beta-catenin downstream of the APC/Axin/GSK3beta complex.","method":"Co-immunoprecipitation, direct binding assay, overexpression/dominant-negative experiments","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 1/2 — direct binding mapped to phosphorylation sites, functional degradation assay","pmids":["10074433"],"is_preprint":false},{"year":2000,"finding":"APC protein moves along microtubules and concentrates as granules at their growing plus-ends in epithelial cells during cell spreading and wound healing; when MTs shorten, APC granules drop off the ends; the COOH-terminal region targets APC to growing MT ends, while the region lacking COOH-terminus forms granules that move along MTs in an ATP-dependent manner.","method":"GFP-fusion live cell imaging, deletion mutant analysis, immunoelectron microscopy","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1/2 — live imaging of full-length and deletion mutants in epithelial cells with ultrastructural confirmation","pmids":["10662776"],"is_preprint":false},{"year":2001,"finding":"Crystal structure of the beta-catenin arm repeat domain in complex with E-cadherin cytoplasmic domain reveals that APC contains sequences homologous to the phosphorylated region of E-cadherin, suggesting APC competes with E-cadherin for an overlapping binding surface on beta-catenin in a phosphorylation-dependent manner.","method":"X-ray crystallography with functional mutant validation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — atomic structure with mechanistic interpretation validated by sequence homology analysis","pmids":["11348595"],"is_preprint":false},{"year":2002,"finding":"CKIalpha (casein kinase Ialpha) is an Axin-associated kinase that phosphorylates beta-catenin at Ser45 as a priming event required for subsequent GSK-3beta phosphorylation; this dual-kinase mechanism within the APC/Axin destruction complex initiates the beta-catenin phosphorylation-degradation cascade, and Wnt signaling suppresses the CKIalpha priming step.","method":"In vitro kinase assay, mass spectrometry, phospho-specific antibodies, depletion experiments in Xenopus embryos","journal":"Cell / Genes & development","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with identified kinase, phosphorylation site mapping by MS, in vivo validation","pmids":["11955436","12000790"],"is_preprint":false},{"year":2002,"finding":"APC protein shuttles between multiple subcellular destinations including the cytoplasm, plasma membrane, microtubule plus-ends at the cell leading edge, and the nucleus, with each localization linked to distinct cellular functions including Wnt signaling regulation, cell migration, and chromosome stability.","method":"Immunofluorescence, GFP-tagging, fractionation studies (review of multiple experimental papers)","journal":"Nature reviews. Molecular cell biology","confidence":"High","confidence_rationale":"Tier 2 — synthesis of multiple direct localization experiments with functional consequences","pmids":["11988767"],"is_preprint":false},{"year":2007,"finding":"Simultaneous deletion of both Apc and Myc in the adult murine small intestine rescues the perturbed differentiation, migration, proliferation and apoptosis phenotypes caused by Apc loss alone, despite high nuclear beta-catenin levels; Myc is required for the majority of Wnt target gene activation following Apc loss, establishing Myc as the critical downstream mediator of early Apc-loss-driven neoplasia.","method":"Conditional double-knockout mouse model (in vivo deletion), array analysis, histological and cell biological phenotyping","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1/2 — genetic epistasis by double conditional knockout with multiple orthogonal readouts","pmids":["17377531"],"is_preprint":false},{"year":2007,"finding":"BubR1 kinetochore kinase interacts with APC and EB1 in Xenopus egg extracts; BubR1 directly phosphorylates APC in vitro and forms a ternary complex with APC and microtubules; immunodepletion shows BubR1 kinase activity is essential for chromosome positioning at the metaphase plate, and this requires APC/EB1 complex formation for stable kinetochore-microtubule attachment.","method":"Xenopus egg extract immunodepletion, antibody addition, purified component reconstitution, in vitro kinase assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted ternary complex with purified proteins plus functional epistasis by depletion","pmids":["17709426"],"is_preprint":false},{"year":2007,"finding":"Prostate-specific deletion of Apc in mice causes fully penetrant prostate hyperplasia and adenocarcinoma associated with elevated beta-catenin protein levels and high proliferation, demonstrating that APC loss-mediated Wnt/beta-catenin activation is sufficient to drive prostate carcinogenesis.","method":"Conditional Cre-mediated knockout (probasin-Cre), histopathology, immunohistochemistry","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — fully penetrant in vivo model with molecular pathway confirmation","pmids":["17363566"],"is_preprint":false},{"year":2008,"finding":"APC interacts with nuclear pore complex protein Nup153 (nucleoporin 153) through its middle region, and this interaction promotes association of microtubules with the nuclear membrane; this function is required for polarization of the microtubule cytoskeleton during directional cell migration.","method":"Co-immunoprecipitation, GFP-localization, dominant-negative expression, scratch-wound migration assay","journal":"Biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2/3 — co-IP of endogenous proteins plus functional migration assay, single lab","pmids":["18042042"],"is_preprint":false},{"year":2008,"finding":"APC regulates DNA base excision repair (BER) through interaction with DNA polymerase beta (Pol-beta) and flap endonuclease 1 (Fen-1), and APC gene transcription is activated by alkylating agents, suggesting APC modulates whether DNA-damaged cells survive or undergo apoptosis.","method":"Interaction assays, BER activity measurement, transcriptional induction assays (review synthesizing experimental data)","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 3 — multiple interaction studies from single group, no structural validation","pmids":["18662849"],"is_preprint":false},{"year":2009,"finding":"APC associates with mitotic spindle microtubules at their plus-ends at kinetochores; genetic and functional experiments show APC regulates spindle microtubule dynamics through EB1 interaction; APC is required for the spindle checkpoint to detect transiently misaligned chromosomes; truncated APC alleles act dominantly to inhibit the mitotic spindle, placing chromosome instability at the earliest stage of colorectal cancer.","method":"Immunofluorescence, genetic epistasis in yeast and mammalian cells, dominant-negative expression, spindle checkpoint assays","journal":"Advances in experimental medicine and biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (localization, genetics, functional checkpoint assay) in multiple systems","pmids":["19928352"],"is_preprint":false},{"year":2009,"finding":"Nup358 (RanBP2) interacts with the middle region of APC (a region with microtubule plus-end-targeting activity), cooperates with kinesin-2 in a nuclear-transport-independent mechanism to regulate APC localization to the cell cortex, and is required for polarized cell migration as shown by RNAi knockdown in wound-healing assays.","method":"Co-immunoprecipitation, ectopic expression, RNAi knockdown, scratch-wound migration assay, MT plus-end tracking","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal interactions plus functional RNAi phenotype, single lab","pmids":["19654215"],"is_preprint":false},{"year":2009,"finding":"Nuclear APC contains two classical nuclear localization signals and nuclear export signals enabling shuttling between nucleus and cytoplasm; nuclear APC opposes beta-catenin-mediated transcription through nuclear sequestration of beta-catenin and interaction with transcriptional corepressor CtBP; additional nuclear partners include AP-2alpha, Crm1, PTP-BL, DNA polymerase beta, and PCNA.","method":"NLS/NES mapping, nuclear import/export assays, co-immunoprecipitation, transcription reporter assays","journal":"Advances in experimental medicine and biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods defining nuclear trafficking signals and functional transcriptional repression","pmids":["19928349"],"is_preprint":false},{"year":2010,"finding":"Microflora-MyD88-ERK signaling in intestinal epithelial cells promotes tumorigenesis in Apc(min/+) mice by phosphorylating c-Myc to prevent its ubiquitination and proteasomal degradation; Apc(min/+)/Myd88(-/-) mice have lower p-ERK and fewer/smaller tumors; ERK inhibitor suppresses tumorigenesis, establishing a microflora-TLR-ERK-Myc axis downstream of Apc loss.","method":"Genetic epistasis (double knockout), biochemical phosphorylation assay, pharmacological inhibition, in vivo tumor analysis","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic and pharmacological epistasis with defined molecular mechanism","pmids":["20473309"],"is_preprint":false},{"year":2012,"finding":"Wnt signaling does not disassemble the APC/Axin1 destruction complex nor inhibit phosphorylation of Axin1-bound beta-catenin; instead, Wnt suppresses beta-catenin ubiquitination within an intact complex, leading to complex saturation by phospho-beta-catenin, so that newly synthesized beta-catenin accumulates in free cytosolic form and engages nuclear TCF factors.","method":"Endogenous protein immunoprecipitation, phosphorylation assays, ubiquitination assays, proteasome inhibition, intestinal organoids","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — mechanistic dissection of destruction complex at endogenous levels in multiple cell systems including primary intestinal epithelium","pmids":["22682247"],"is_preprint":false},{"year":2013,"finding":"APC regulates the miR-17-92 cluster through the beta-catenin pathway: activated beta-catenin resulting from APC loss binds to and activates the miR-17-92 promoter; enforced expression of miR-19a overrides APC tumor suppressor activity, and knockdown of miR-19a reduces aggressive features in cells with compromised APC.","method":"APC-inducible cell line, miRNA array, ChIP, promoter reporter assay, miRNA overexpression/knockdown","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (ChIP, reporter, functional rescue) from single lab","pmids":["26804172"],"is_preprint":false},{"year":2013,"finding":"Phosphorylated beta-catenin preferentially binds to the 15 amino acid repeats (15R) of APC rather than the first 20 amino acid repeat, suggesting the 15R region constitutes a gate connecting beta-catenin phosphorylation and subsequent ubiquitination/degradation; truncated APC in colorectal tumors almost always retains at least one 15R, and APCL (APC2 paralog) uses the 15R of truncated APC via heterodimerization to target beta-catenin for degradation.","method":"RNA interference, domain-swap experiments, co-immunoprecipitation, beta-catenin degradation assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal approaches (RNAi, domain swaps, co-IP) defining mechanistic step, single lab","pmids":["23840886"],"is_preprint":false},{"year":2021,"finding":"METTL3 upregulates m6A modification of APC mRNA, which recruits YTHDF protein to promote APC mRNA degradation; reduced APC expression then increases beta-catenin and downstream targets (cyclin D1, c-Myc, PKM2), promoting aerobic glycolysis and tumor formation in esophageal squamous cell carcinoma.","method":"m6A-RIP sequencing, RNA immunoprecipitation, METTL3 knockdown/overexpression, YTHDF binding assay, xenograft mouse model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — m6A-RIP-seq, direct YTHDF binding, functional rescue in vivo, multiple orthogonal methods","pmids":["34155197"],"is_preprint":false},{"year":2021,"finding":"The kinesin motor KIF1C interacts with APC-dependent mRNAs and is required for their transport to cytoplasmic protrusions; live two-color imaging directly shows single mRNAs transported by single KIF1C motors; the 3'UTR of APC-dependent mRNAs is sufficient to trigger KIF1C-dependent transport, and KIF1C also clusters these mRNAs at the periphery.","method":"RNA immunoprecipitation, live single-molecule imaging (two-color), siRNA knockdown, 3'UTR sufficiency assay","journal":"RNA","confidence":"High","confidence_rationale":"Tier 1/2 — direct single-molecule visualization of transport plus mechanistic dissection of 3'UTR requirement","pmids":["34493599"],"is_preprint":false},{"year":2022,"finding":"APC regulates both actin and microtubule cytoskeletons during cell migration; APC at microtubule plus-ends can stimulate Arp2/3 complex-dependent nucleation of branched actin filament networks via intermediate signaling events, linking microtubule dynamics to leading-edge protrusion through APC as an intermediate.","method":"Live-cell imaging, FRAP, actin nucleation assays, loss-of-function experiments (review integrating experimental data)","journal":"European journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2/3 — synthesis of multiple experimental approaches from multiple labs, mechanistic model supported by functional data","pmids":["35483122"],"is_preprint":false}],"current_model":"APC is a multifunctional tumor suppressor that acts as a scaffold in the beta-catenin destruction complex (with Axin, CKIalpha, and GSK3beta) to promote sequential phosphorylation and ubiquitin-proteasome-dependent degradation of beta-catenin, thereby suppressing Wnt/TCF target gene transcription including c-Myc; APC additionally localizes to microtubule plus-ends (via EB1 interaction and KIF1C-dependent transport), the nuclear membrane (via Nup358), and the nucleus (where it represses beta-catenin transcription via CtBP and participates in DNA repair via Pol-beta and Fen-1), and contributes to chromosomal stability through kinetochore-microtubule attachment regulation and the spindle checkpoint."},"narrative":{"teleology":[{"year":1991,"claim":"Positional cloning of the APC gene at 5q21 and identification of truncating germline mutations in FAP patients established APC as the causal tumor suppressor for hereditary colorectal polyposis.","evidence":"Positional cloning and SSCP/DNA sequencing in FAP kindreds and sporadic colorectal cancers","pmids":["1651174","1651562","1651563","1678319"],"confidence":"High","gaps":["Protein function was unknown at the time of cloning","Mechanism linking APC loss to tumorigenesis was entirely undefined"]},{"year":1993,"claim":"Discovery that APC directly binds β-catenin through 15-amino-acid repeats provided the first molecular link between APC and the cell adhesion/signaling machinery, reframing APC as a regulator of catenin biology rather than a conventional growth-factor pathway component.","evidence":"Reciprocal co-immunoprecipitation and peptide mapping in epithelial cell lines","pmids":["8259518","8259519"],"confidence":"High","gaps":["Whether APC regulated β-catenin levels or only its adhesive function was unresolved","Kinase and ubiquitin-ligase components of the pathway were unknown"]},{"year":1995,"claim":"Identification of EB1 as an APC C-terminal binding partner revealed a second functional axis—microtubule plus-end association—distinct from the β-catenin regulatory role.","evidence":"Yeast two-hybrid, in vitro binding, and co-immunoprecipitation","pmids":["7606712"],"confidence":"High","gaps":["Functional consequence of APC–EB1 interaction for cell division was undefined","Whether the C-terminus was relevant to tumor suppression remained unclear"]},{"year":1996,"claim":"Demonstration that GSK-3β phosphorylates APC and that this phosphorylation is required for high-affinity β-catenin binding established the enzymatic logic of the destruction complex—kinase activity modulates the scaffold's ability to capture its substrate.","evidence":"In vitro kinase assay, phosphorylation site mapping, co-immunoprecipitation","pmids":["8638126"],"confidence":"High","gaps":["The scaffold protein Axin had not yet been placed in the complex","Priming kinase upstream of GSK-3β was unknown"]},{"year":1998,"claim":"Identification of Axin as the central scaffold that directly binds APC, β-catenin, and GSK-3β, and dramatically enhances GSK-3β-dependent phosphorylation, completed the core architecture of the destruction complex.","evidence":"Reconstituted quaternary complex with purified components, co-immunoprecipitation from cells, in vitro kinase assays","pmids":["9601641","9482734"],"confidence":"High","gaps":["Priming phosphorylation step was still missing","Ubiquitin-ligase link to proteasomal degradation was not yet defined"]},{"year":2002,"claim":"Identification of CKIα as the priming kinase that phosphorylates β-catenin at Ser45 within the Axin-bound complex, prerequisite for GSK-3β processivity, completed the dual-kinase phosphorylation cascade and explained how Wnt signaling blocks the initial trigger of β-catenin degradation.","evidence":"In vitro kinase assay, mass spectrometry, phospho-specific antibodies, Xenopus embryo depletion","pmids":["11955436","12000790"],"confidence":"High","gaps":["How Wnt signaling mechanistically inhibits destruction complex output was still debated","Structural basis for CKIα priming within the complex was unknown"]},{"year":2007,"claim":"Genetic epistasis showing that simultaneous Myc deletion rescues the proliferative and differentiation defects of Apc loss in intestinal epithelium established c-Myc as the critical transcriptional effector of Wnt pathway activation downstream of APC, defining the key oncogenic output of APC mutations.","evidence":"Conditional double-knockout mouse model with histological and transcriptomic phenotyping","pmids":["17377531"],"confidence":"High","gaps":["Whether Myc dependence extends to late-stage carcinomas was untested","Additional Wnt targets contributing to full malignant progression were not excluded"]},{"year":2007,"claim":"Reconstitution of a BubR1–APC–EB1 ternary complex and demonstration that BubR1 phosphorylates APC to regulate kinetochore–microtubule attachments established a mitotic function for APC separate from Wnt signaling, linking APC truncation to chromosomal instability.","evidence":"Xenopus egg extract immunodepletion, in vitro kinase assay, purified ternary complex","pmids":["17709426"],"confidence":"High","gaps":["Relative contribution of chromosomal instability versus Wnt activation to tumorigenesis was unresolved","APC phosphorylation sites by BubR1 and their structural consequences were not mapped"]},{"year":2012,"claim":"Demonstration that Wnt signaling does not disassemble the destruction complex but instead suppresses β-catenin ubiquitination within an intact complex—causing its saturation and accumulation of free cytosolic β-catenin—fundamentally revised the model of how APC/Axin regulate β-catenin flux.","evidence":"Endogenous immunoprecipitation, phosphorylation and ubiquitination assays, proteasome inhibition, intestinal organoids","pmids":["22682247"],"confidence":"High","gaps":["Molecular mechanism by which Wnt inhibits the ubiquitination step within the intact complex remains structurally unresolved","Whether saturation model applies equivalently across all tissue types is untested"]},{"year":2021,"claim":"Single-molecule imaging revealed KIF1C-dependent transport of APC-associated mRNAs to cytoplasmic protrusions via 3′UTR-encoded signals, establishing a post-transcriptional logistics role for APC in polarized mRNA localization beyond its canonical protein-level functions.","evidence":"Live two-color single-molecule imaging, RNA immunoprecipitation, siRNA knockdown, 3′UTR sufficiency assay","pmids":["34493599"],"confidence":"High","gaps":["Whether APC protein itself directly contacts the mRNA or acts through adaptor proteins is unclear","Functional consequences of mRNA mislocalization in APC-mutant tumors are not defined"]},{"year":null,"claim":"A high-resolution structural model of the full destruction complex—showing how APC, Axin, CKIα, GSK-3β, and β-TrCP coordinate β-catenin capture, processivity of dual phosphorylation, and handoff to the ubiquitin ligase—remains unavailable, limiting mechanistic understanding of how specific APC truncations differentially affect complex activity.","evidence":"","pmids":[],"confidence":"High","gaps":["No full-length APC structure exists","How APC truncation positions (MCR variations) quantitatively alter destruction complex output is undefined","Relative contributions of chromosomal instability, Wnt deregulation, and BER deficiency to APC-driven tumorigenesis are not quantitatively partitioned"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[9,10,14,25]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[6,12,17,21,30]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,11,25,27]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4,15,25]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[12,17,21,30]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[15,23]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,15,22]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[17,21]},{"term_id":"GO:0005635","term_label":"nuclear envelope","supporting_discovery_ids":[19,22]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,7,9,10,14,25]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[17,21]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[8]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,1,16,18]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[11,14,25]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[20]}],"complexes":["β-catenin destruction complex (APC/Axin/GSK-3β/CKIα)","APC–EB1–BubR1 kinetochore complex"],"partners":["CTNNB1","AXIN1","GSK3B","CSNK1A1","MAPRE1","BUBR1","CTBP1","NUP358"],"other_free_text":[]},"mechanistic_narrative":"APC is a multifunctional tumor suppressor that serves as the central scaffold of the β-catenin destruction complex, recruiting Axin, GSK-3β, and CKIα to drive sequential phosphorylation of β-catenin at Ser45 (CKIα priming) and subsequent GSK-3β sites, thereby licensing β-TrCP-mediated ubiquitination and proteasomal degradation of β-catenin and suppressing Wnt/TCF target gene transcription—most critically c-Myc, which is the essential downstream effector of APC-loss-driven intestinal neoplasia [PMID:9601641, PMID:11955436, PMID:22682247, PMID:17377531]. Germline truncating mutations in APC cause familial adenomatous polyposis (FAP), and somatic APC truncations—clustered in the mutation cluster region of exon 15—are found in >80% of sporadic colorectal cancers [PMID:1651174, PMID:1338904]. Beyond Wnt regulation, APC localizes to microtubule plus-ends via its C-terminal EB1-binding domain, contributes to kinetochore–microtubule attachment and the spindle assembly checkpoint through a BubR1–EB1 ternary complex, and coordinates actin-based protrusion during polarized cell migration [PMID:10662776, PMID:17709426, PMID:19928352, PMID:35483122]. APC also shuttles into the nucleus where it represses β-catenin/TCF transcription via CtBP interaction and participates in DNA base excision repair through associations with DNA polymerase β and Fen-1 [PMID:19928349, PMID:18662849]."},"prefetch_data":{"uniprot":{"accession":"P25054","full_name":"Adenomatous polyposis coli protein","aliases":["Deleted in polyposis 2.5"],"length_aa":2843,"mass_kda":311.6,"function":"Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Associates with both microtubules and actin filaments, components of the cytoskeleton (PubMed:17293347). Plays a role in mediating the organization of F-actin into ordered bundles (PubMed:17293347). Functions downstream of Rho GTPases and DIAPH1 to selectively stabilize microtubules (By similarity). Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization","subcellular_location":"Cell junction, adherens junction; Cytoplasm, cytoskeleton; Cell projection, lamellipodium; Cell projection, ruffle membrane; Cytoplasm; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P25054/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/APC","classification":"Not Classified","n_dependent_lines":382,"n_total_lines":1208,"dependency_fraction":0.3162251655629139},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000134982","cell_line_id":"CID000685","localizations":[{"compartment":"membrane","grade":3},{"compartment":"cytoplasmic","grade":2},{"compartment":"centrosome","grade":1}],"interactors":[{"gene":"CTNNB1","stoichiometry":0.2},{"gene":"TRAP1","stoichiometry":0.2},{"gene":"COPZ1","stoichiometry":0.2},{"gene":"DDX21","stoichiometry":0.2},{"gene":"GSK3B","stoichiometry":0.2},{"gene":"MAPRE1","stoichiometry":0.2},{"gene":"TUBB4B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000685","total_profiled":1310},"omim":[{"mim_id":"621363","title":"MAP7 DOMAIN-CONTAINING PROTEIN 1; MAP7D1","url":"https://www.omim.org/entry/621363"},{"mim_id":"620959","title":"UBIQUITIN-SPECIFIC PEPTIDASE 35; USP35","url":"https://www.omim.org/entry/620959"},{"mim_id":"620226","title":"UBIQUITIN-SPECIFIC PEPTIDASE 37; USP37","url":"https://www.omim.org/entry/620226"},{"mim_id":"620145","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 109; DEE109","url":"https://www.omim.org/entry/620145"},{"mim_id":"620142","title":"CENTROSOMAL AT-AC SPLICING FACTOR; CENATAC","url":"https://www.omim.org/entry/620142"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":38.7}],"url":"https://www.proteinatlas.org/search/APC"},"hgnc":{"alias_symbol":["DP2","DP3","DP2.5","PPP1R46"],"prev_symbol":[]},"alphafold":{"accession":"P25054","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P25054","model_url":"","pae_url":"","plddt_mean":null},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=APC","jax_strain_url":"https://www.jax.org/strain/search?query=APC"},"sequence":{"accession":"P25054","fasta_url":"https://rest.uniprot.org/uniprotkb/P25054.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P25054/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P25054"}},"corpus_meta":[{"pmid":"8259518","id":"PMC_8259518","title":"Association of the APC gene product with beta-catenin.","date":"1993","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8259518","citation_count":1202,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11257105","id":"PMC_11257105","title":"The ABC of APC.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11257105","citation_count":692,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17377531","id":"PMC_17377531","title":"Myc deletion rescues Apc deficiency in the small intestine.","date":"2007","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/17377531","citation_count":504,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8755583","id":"PMC_8755583","title":"Apoptosis and APC in colorectal tumorigenesis.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8755583","citation_count":439,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8385345","id":"PMC_8385345","title":"The APC gene product in normal and tumor cells.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8385345","citation_count":428,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7606712","id":"PMC_7606712","title":"APC binds to the novel protein EB1.","date":"1995","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7606712","citation_count":392,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18941170","id":"PMC_18941170","title":"Macrophages as APC and the dendritic cell myth.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18941170","citation_count":380,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9196022","id":"PMC_9196022","title":"The adenomatous polyposis coli (APC) tumor suppressor.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9196022","citation_count":375,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17881494","id":"PMC_17881494","title":"Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene.","date":"2007","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17881494","citation_count":364,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11978510","id":"PMC_11978510","title":"The APC gene in colorectal cancer.","date":"2002","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/11978510","citation_count":296,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12473343","id":"PMC_12473343","title":"Regulation of APC-Cdc20 by the spindle checkpoint.","date":"2002","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12473343","citation_count":289,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18598214","id":"PMC_18598214","title":"Regulation of APC/C activators in mitosis and meiosis.","date":"2008","source":"Annual review of cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18598214","citation_count":256,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10662776","id":"PMC_10662776","title":"Adenomatous polyposis coli (APC) protein moves along microtubules and concentrates at their growing ends in epithelial cells.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10662776","citation_count":244,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11448917","id":"PMC_11448917","title":"Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.","date":"2001","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/11448917","citation_count":220,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11988767","id":"PMC_11988767","title":"The subcellular destinations of APC proteins.","date":"2002","source":"Nature reviews. Molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11988767","citation_count":206,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15749909","id":"PMC_15749909","title":"Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15749909","citation_count":174,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20473309","id":"PMC_20473309","title":"ERK activation drives intestinal tumorigenesis in Apc(min/+) mice.","date":"2010","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20473309","citation_count":167,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23589490","id":"PMC_23589490","title":"Panta rhei: the APC/C at steady state.","date":"2013","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23589490","citation_count":165,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18787127","id":"PMC_18787127","title":"Atypical E2F activity restrains APC/CCCS52A2 function obligatory for endocycle onset.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18787127","citation_count":145,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34155197","id":"PMC_34155197","title":"METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34155197","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11964384","id":"PMC_11964384","title":"APC/Fizzy-Related targets Aurora-A kinase for proteolysis.","date":"2002","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/11964384","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17114580","id":"PMC_17114580","title":"Precise destruction: an emerging picture of the APC.","date":"2006","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17114580","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18538487","id":"PMC_18538487","title":"Apc mice: models, modifiers and mutants.","date":"2008","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/18538487","citation_count":126,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9210368","id":"PMC_9210368","title":"Carcinogenesis: a balance between beta-catenin and APC.","date":"1997","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/9210368","citation_count":126,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24871945","id":"PMC_24871945","title":"APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction.","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/24871945","citation_count":124,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27114510","id":"PMC_27114510","title":"Mechanism of APC/CCDC20 activation by mitotic phosphorylation.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27114510","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10459014","id":"PMC_10459014","title":"Regulation of APC activity by phosphorylation and regulatory factors.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10459014","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18544349","id":"PMC_18544349","title":"To cell cycle, swing the APC/C.","date":"2008","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18544349","citation_count":114,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11437404","id":"PMC_11437404","title":"Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers.","date":"2001","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11437404","citation_count":114,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9736712","id":"PMC_9736712","title":"Mad2 transiently associates with an APC/p55Cdc complex during mitosis.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9736712","citation_count":114,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29282223","id":"PMC_29282223","title":"Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29282223","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8764128","id":"PMC_8764128","title":"Somatic mutations of the APC gene in sporadic hepatoblastomas.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8764128","citation_count":107,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20356827","id":"PMC_20356827","title":"Crystal structure of HLA-DP2 and implications for chronic beryllium disease.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20356827","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23883517","id":"PMC_23883517","title":"AMPKα1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling.","date":"2013","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/23883517","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15978106","id":"PMC_15978106","title":"Determinants of the APTT- and ETP-based APC sensitivity tests.","date":"2005","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/15978106","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16185824","id":"PMC_16185824","title":"Non-traditional roles for the Adenomatous Polyposis Coli (APC) tumor suppressor protein.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16185824","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11099951","id":"PMC_11099951","title":"The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.","date":"2000","source":"Molecular medicine today","url":"https://pubmed.ncbi.nlm.nih.gov/11099951","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7784053","id":"PMC_7784053","title":"Cloning and characterization of human DP2, a novel dimerization partner of E2F.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7784053","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20002539","id":"PMC_20002539","title":"APC resistance: biological basis and acquired influences.","date":"2009","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/20002539","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17363566","id":"PMC_17363566","title":"Inactivation of Apc in the mouse prostate causes prostate carcinoma.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17363566","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21439394","id":"PMC_21439394","title":"Mutual regulation between the spindle checkpoint and APC/C.","date":"2011","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21439394","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17572842","id":"PMC_17572842","title":"Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia.","date":"2007","source":"Medical molecular morphology","url":"https://pubmed.ncbi.nlm.nih.gov/17572842","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9176082","id":"PMC_9176082","title":"APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis.","date":"1997","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/9176082","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18848448","id":"PMC_18848448","title":"APC shuttling to the membrane, nucleus and beyond.","date":"2008","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18848448","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7585543","id":"PMC_7585543","title":"Biallelic inactivation of the APC gene in hepatoblastoma.","date":"1995","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7585543","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31164978","id":"PMC_31164978","title":"APC/C: current understanding and future perspectives.","date":"2019","source":"F1000Research","url":"https://pubmed.ncbi.nlm.nih.gov/31164978","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20010873","id":"PMC_20010873","title":"Complete deletion of Apc results in severe polyposis in mice.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20010873","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26973250","id":"PMC_26973250","title":"Olfactomedin 4 deletion induces colon adenocarcinoma in ApcMin/+ mice.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26973250","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15326380","id":"PMC_15326380","title":"APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q.","date":"2004","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/15326380","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25043943","id":"PMC_25043943","title":"Expansion of the APC superfamily of secondary carriers.","date":"2014","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/25043943","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12902465","id":"PMC_12902465","title":"Mechanisms of ganglioside inhibition of APC function.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12902465","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12490611","id":"PMC_12490611","title":"15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.","date":"2003","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/12490611","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11564752","id":"PMC_11564752","title":"Where is APC going?","date":"2001","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11564752","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12499257","id":"PMC_12499257","title":"Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12499257","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29743346","id":"PMC_29743346","title":"PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN-λ production.","date":"2018","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29743346","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23708654","id":"PMC_23708654","title":"PIK3CA and APC mutations are synergistic in the development of intestinal cancers.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23708654","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17709426","id":"PMC_17709426","title":"BubR1 and APC/EB1 cooperate to maintain metaphase chromosome alignment.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17709426","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29148535","id":"PMC_29148535","title":"The role of APC in WNT pathway activation in serrated neoplasia.","date":"2017","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/29148535","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18519734","id":"PMC_18519734","title":"Original CIN: reviewing roles for APC in chromosome instability.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18519734","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25323233","id":"PMC_25323233","title":"Prostaglandin D2 and the role of the DP1, DP2 and TP receptors in the control of airway reflex events.","date":"2014","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/25323233","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23775192","id":"PMC_23775192","title":"The spindle checkpoint, APC/C(Cdc20), and APC/C(Cdh1) play distinct roles in connecting mitosis to S phase.","date":"2013","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23775192","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25268140","id":"PMC_25268140","title":"Expression of DP2 (CRTh2), a prostaglandin D₂ receptor, in human mast cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25268140","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19197353","id":"PMC_19197353","title":"Genetic mechanisms in Apc-mediated mammary tumorigenesis.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19197353","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18662849","id":"PMC_18662849","title":"A novel function of adenomatous polyposis coli (APC) in regulating DNA repair.","date":"2008","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/18662849","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15004149","id":"PMC_15004149","title":"Prolonged antigen presentation, APC-, and CD8+ T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15004149","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26804172","id":"PMC_26804172","title":"Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26804172","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26279473","id":"PMC_26279473","title":"Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival.","date":"2015","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26279473","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11956582","id":"PMC_11956582","title":"No evidence for involvement of beta-catenin and APC in urothelial carcinomas.","date":"2002","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/11956582","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16158975","id":"PMC_16158975","title":"Adenomatous polyposis coli (Apc) tumor suppressor gene as a multifunctional gene.","date":"2005","source":"Anatomical science international","url":"https://pubmed.ncbi.nlm.nih.gov/16158975","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14595746","id":"PMC_14595746","title":"Cadherins, catenins and APC in pleural malignant mesothelioma.","date":"2003","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/14595746","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19928352","id":"PMC_19928352","title":"The role of APC in mitosis and in chromosome instability.","date":"2009","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/19928352","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19646806","id":"PMC_19646806","title":"Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice.","date":"2009","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/19646806","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9012588","id":"PMC_9012588","title":"Genotype-phenotype correlations at the adenomatous polyposis coli (APC) gene.","date":"1995","source":"Critical reviews in oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/9012588","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19928350","id":"PMC_19928350","title":"APC in cell migration.","date":"2009","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/19928350","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25142465","id":"PMC_25142465","title":"Prostaglandin D2 acts through the Dp2 receptor to influence male germ cell differentiation in the foetal mouse testis.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25142465","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28818625","id":"PMC_28818625","title":"The therapeutic potential of CRTH2/DP2 beyond allergy and asthma.","date":"2017","source":"Prostaglandins & other lipid mediators","url":"https://pubmed.ncbi.nlm.nih.gov/28818625","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20615077","id":"PMC_20615077","title":"DP(2) receptor antagonists in development.","date":"2010","source":"Expert opinion on investigational drugs","url":"https://pubmed.ncbi.nlm.nih.gov/20615077","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34493599","id":"PMC_34493599","title":"The kinesin KIF1C transports APC-dependent mRNAs to cell protrusions.","date":"2021","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/34493599","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21095110","id":"PMC_21095110","title":"Basophils as APC in Th2 response in allergic inflammation and parasite infection.","date":"2010","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21095110","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24900359","id":"PMC_24900359","title":"Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists.","date":"2011","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/24900359","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19928349","id":"PMC_19928349","title":"Nuclear APC.","date":"2009","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/19928349","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24073896","id":"PMC_24073896","title":"Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs.","date":"2013","source":"Expert opinion on investigational drugs","url":"https://pubmed.ncbi.nlm.nih.gov/24073896","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18042042","id":"PMC_18042042","title":"APC nuclear membrane association and microtubule polarity.","date":"2008","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18042042","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16951350","id":"PMC_16951350","title":"Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16951350","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23505121","id":"PMC_23505121","title":"COX-1-dependent prostaglandin D2 in microglia contributes to neuropathic pain via DP2 receptor in spinal neurons.","date":"2013","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/23505121","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33968756","id":"PMC_33968756","title":"APC Promoter Methylation in Gastrointestinal Cancer.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33968756","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21557638","id":"PMC_21557638","title":"Antigen-presenting cell (APC) subsets in ovarian cancer.","date":"2011","source":"International reviews of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21557638","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24698234","id":"PMC_24698234","title":"15-deoxy-Δ¹²,¹⁴-PGJ₂ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis.","date":"2014","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/24698234","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21874044","id":"PMC_21874044","title":"Regulation of APC/CCdc20 activity by RASSF1A-APC/CCdc20 circuitry.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21874044","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11112217","id":"PMC_11112217","title":"Nasopharyngeal angiofibroma: an APC-gene-associated tumor?","date":"2000","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11112217","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28978643","id":"PMC_28978643","title":"Chromosome biorientation and APC activity remain uncoupled in oocytes with reduced volume.","date":"2017","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28978643","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20434453","id":"PMC_20434453","title":"Allele-specific expression of APC in adenomatous polyposis families.","date":"2010","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/20434453","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19654215","id":"PMC_19654215","title":"Nup358 interacts with APC and plays a role in cell polarization.","date":"2009","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/19654215","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10970088","id":"PMC_10970088","title":"Alterations of adenomatous polyposis Coli (APC) gene in oral squamous cell carcinoma.","date":"2000","source":"International journal of oral and maxillofacial surgery","url":"https://pubmed.ncbi.nlm.nih.gov/10970088","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9297533","id":"PMC_9297533","title":"Antigen processing differences among APC.","date":"1997","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9297533","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15380172","id":"PMC_15380172","title":"Expression of adenomatous polyposis coli (APC) in tumorigenesis of human oral squamous cell carcinoma.","date":"2004","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/15380172","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35483122","id":"PMC_35483122","title":"Adenomatous Polyposis Coli (APC) in cell migration.","date":"2022","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35483122","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27145271","id":"PMC_27145271","title":"EphB6 overexpression and Apc mutation together promote colorectal cancer.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27145271","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11903580","id":"PMC_11903580","title":"Adenomatous polyposis coli (APC), beta-catenin, and cadherin are expressed in human bone and cartilage.","date":"2001","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/11903580","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23840886","id":"PMC_23840886","title":"Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23840886","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1651174","id":"PMC_1651174","title":"Identification and characterization of the familial adenomatous polyposis coli gene.","date":"1991","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1651174","citation_count":2411,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1651562","id":"PMC_1651562","title":"Identification of FAP locus genes from chromosome 5q21.","date":"1991","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/1651562","citation_count":2071,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23788249","id":"PMC_23788249","title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.","date":"2013","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23788249","citation_count":1945,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11955436","id":"PMC_11955436","title":"Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11955436","citation_count":1758,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1651563","id":"PMC_1651563","title":"Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.","date":"1991","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/1651563","citation_count":1669,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16964243","id":"PMC_16964243","title":"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.","date":"2006","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/16964243","citation_count":1336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8638126","id":"PMC_8638126","title":"Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8638126","citation_count":1275,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8259519","id":"PMC_8259519","title":"Association of the APC tumor suppressor protein with catenins.","date":"1993","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8259519","citation_count":1142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9482734","id":"PMC_9482734","title":"Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9482734","citation_count":1086,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22056988","id":"PMC_22056988","title":"Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22056988","citation_count":920,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11076863","id":"PMC_11076863","title":"DNA cloning using in vitro site-specific recombination.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11076863","citation_count":815,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7661930","id":"PMC_7661930","title":"The molecular basis of Turcot's syndrome.","date":"1995","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7661930","citation_count":770,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9601641","id":"PMC_9601641","title":"Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.","date":"1998","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/9601641","citation_count":739,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22682247","id":"PMC_22682247","title":"Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22682247","citation_count":734,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1678319","id":"PMC_1678319","title":"Identification of deletion mutations and three new genes at the familial polyposis locus.","date":"1991","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1678319","citation_count":716,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11348595","id":"PMC_11348595","title":"The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin.","date":"2001","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11348595","citation_count":653,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1338904","id":"PMC_1338904","title":"Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.","date":"1992","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1338904","citation_count":651,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12000790","id":"PMC_12000790","title":"Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12000790","citation_count":610,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12952940","id":"PMC_12952940","title":"Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12952940","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10074433","id":"PMC_10074433","title":"The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.","date":"1999","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/10074433","citation_count":599,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7806582","id":"PMC_7806582","title":"E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.","date":"1994","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7806582","citation_count":585,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42660,"output_tokens":3662,"usd":0.091455},"stage2":{"model":"claude-opus-4-6","input_tokens":7080,"output_tokens":3420,"usd":0.18135},"total_usd":0.605168,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":54515,"output_tokens":7037,"usd":0.13455},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":10630,"output_tokens":3149,"usd":0.197813}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"APC protein physically associates with beta-catenin (a ~95 kDa protein that binds E-cadherin), as demonstrated by reciprocal co-immunoprecipitation experiments, suggesting APC is involved in cell adhesion and beta-catenin regulation.\",\n      \"method\": \"Co-immunoprecipitation with APC antibodies, purification and sequencing of co-precipitated protein, reciprocal co-IP with beta-catenin antibody\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with protein identification by sequencing, foundational paper with >1200 citations replicated widely\",\n      \"pmids\": [\"8259518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"APC protein (full-length ~300 kDa) is found in the cytoplasm of normal colonic epithelial cells with increased expression in the upper (differentiating) portions of crypts; truncated APC proteins are detected in colorectal tumor cell lines lacking full-length APC.\",\n      \"method\": \"Western blot with APC-specific monoclonal and polyclonal antibodies; immunohistochemistry of normal colonic mucosa\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct protein localization by IHC with functional context (expression pattern correlated with differentiation), confirmed by Western blot\",\n      \"pmids\": [\"8385345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"APC binds the novel protein EB1 through its carboxyl terminus, as identified by yeast two-hybrid screen, confirmed by in vitro binding assays, and demonstrated in vivo by co-immunoprecipitation with anti-EB1 monoclonal antibodies.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro binding assay, co-immunoprecipitation in mammalian cells\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (two-hybrid, in vitro binding, in vivo Co-IP) in single study; widely replicated\",\n      \"pmids\": [\"7606712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Expression of APC in human colorectal cancer cells bearing endogenous inactive APC alleles induces apoptosis and reduces cell growth, establishing APC as a functional regulator of apoptosis.\",\n      \"method\": \"Inducible APC expression system in APC-null colorectal cancer cells; cell growth assays; apoptosis assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function context with defined apoptotic phenotype measured by functional assay; replicated in multiple cell lines\",\n      \"pmids\": [\"8755583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"APC protein moves along microtubules and concentrates at their growing plus ends in epithelial cells; the C-terminal domain targets APC to growing MT ends, while an N-terminal domain drives ATP-dependent movement along MTs. APC granules dissociate from MT ends when microtubules shorten.\",\n      \"method\": \"Live-cell imaging of GFP-tagged full-length and deletion mutants of Xenopus APC in Xenopus epithelial cells; immunoelectron microscopy\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — live imaging of GFP fusions with deletion mapping and immunoelectron microscopy structural confirmation; domain dissection in living cells\",\n      \"pmids\": [\"10662776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Loss of Myc rescues the phenotypes of perturbed differentiation, migration, proliferation, and apoptosis caused by Apc deletion in the murine small intestine, establishing Myc as the critical mediator of early neoplasia following Apc loss downstream of beta-catenin-Tcf4; array analysis showed Myc is required for majority of Wnt target gene activation after Apc loss.\",\n      \"method\": \"Simultaneous conditional deletion of Apc and Myc in adult murine small intestine (Cre-lox); histology; gene expression arrays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis by double conditional knockout with defined phenotypic rescue and transcriptomic validation; highly cited foundational study\",\n      \"pmids\": [\"17377531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BubR1 kinase directly phosphorylates APC and forms a ternary complex with APC and microtubules; BubR1 interacts with APC and EB1 in Xenopus egg extracts, and this complex formation is necessary for metaphase chromosome alignment.\",\n      \"method\": \"Immunodepletion from and antibody addition to Xenopus egg extracts; in vitro kinase assay with purified components; Co-IP in egg extracts\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — reconstitution with purified components, in vitro kinase assay, immunodepletion epistasis, Co-IP\",\n      \"pmids\": [\"17709426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"APC promotes association of microtubule plus-ends with the nuclear membrane through a direct interaction with the nuclear pore complex protein Nup153 (nucleoporin 153), which is required for microtubule cytoskeleton polarization during directional cell migration.\",\n      \"method\": \"Scratch-induced migration assay in primary fibroblasts and astrocytes; co-immunoprecipitation of APC with Nup153; fluorescence microscopy of microtubule organization\",\n      \"journal\": \"Biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — Co-IP plus functional migration assay, single lab study\",\n      \"pmids\": [\"18042042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"APC contains nuclear localization signals and nuclear export signals enabling it to shuttle between nucleus and cytoplasm; nuclear APC opposes beta-catenin-mediated transcription via nuclear sequestration of beta-catenin and interaction with transcriptional co-repressor CtBP.\",\n      \"method\": \"Nuclear localization/export signal mapping; reporter assays for beta-catenin-mediated transcription; Co-IP with CtBP; subcellular fractionation\",\n      \"journal\": \"Advances in experimental medicine and biology (review summarizing experimental findings)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — functional domain mapping and Co-IP data from multiple labs summarized; primary experimental evidence referenced\",\n      \"pmids\": [\"19928349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nup358 (RanBP2) cooperates with kinesin-2 to regulate APC localization to the cell cortex through a nuclear-transport-independent mechanism; APC interacts with Nup358 through its middle region, which has a microtubule plus-end-targeting function, and Nup358 is required for polarized cell migration.\",\n      \"method\": \"Co-immunoprecipitation; ectopic expression of APC middle region domain; RNAi knockdown of Nup358; scratch wound healing assay; immunofluorescence\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — Co-IP, domain mapping, RNAi with functional migration readout; single lab\",\n      \"pmids\": [\"19654215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"APC modulates the base excision repair (BER) pathway through interaction with DNA polymerase beta (Pol-beta) and flap endonuclease 1 (Fen-1), and APC gene transcription is activated by alkylating agents.\",\n      \"method\": \"Co-immunoprecipitation/pulldown of APC with Pol-beta and Fen-1; BER activity assays; transcriptional induction assays\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — direct interaction evidence and functional BER assays summarized from primary work; single lab\",\n      \"pmids\": [\"18662849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"METTL3-mediated N6-methyladenosine (m6A) modification of APC mRNA recruits YTHDF reader proteins, leading to APC mRNA degradation, reduced APC protein, increased beta-catenin stability, and enhanced aerobic glycolysis and cell proliferation.\",\n      \"method\": \"m6A-RIP sequencing; METTL3 overexpression/knockdown; YTHDF co-immunoprecipitation with APC mRNA; luciferase reporter and cell proliferation assays; xenograft tumor formation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (m6A-RIP-seq, RIP, functional assays, in vivo xenograft) demonstrating epitranscriptomic regulation of APC mRNA\",\n      \"pmids\": [\"34155197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The kinesin KIF1C motor interacts with APC-dependent mRNAs and is required for their transport to cytoplasmic protrusions; two-color live imaging directly showed single mRNAs transported by single KIF1C motors along microtubules, with the 3'UTR sufficient to trigger KIF1C-dependent RNA localization.\",\n      \"method\": \"RNA immunoprecipitation; live two-color single-molecule imaging; KIF1C knockdown; 3'UTR reporter constructs; microtubule dependency assays\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — single-molecule live imaging directly demonstrating transport, RIP, 3'UTR sufficiency experiments, and loss-of-function with defined localization phenotype\",\n      \"pmids\": [\"34493599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Phosphorylated beta-catenin preferentially binds the 15 amino acid repeats (15R) of APC rather than the first 20 amino acid repeat; this 15R region acts as a gate connecting the steps of beta-catenin phosphorylation and subsequent ubiquitination/degradation. APC-like (APCL) benefits from the 15R of truncated APC via heterodimerization to target beta-catenin for degradation.\",\n      \"method\": \"Co-immunoprecipitation; RNA interference; domain swapping experiments; functional beta-catenin degradation assays in colon cancer cell lines\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — domain mapping by Co-IP and functional assays; single lab, moderate mechanistic detail\",\n      \"pmids\": [\"23840886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"APC loss-induced activation of beta-catenin directly binds and activates the miR-17-92 cluster promoter; enforced miR-19a expression overrides APC tumor suppressor activity in colorectal cancer cells.\",\n      \"method\": \"APC-inducible cell line; miRNA microarray; beta-catenin ChIP at miR-17-92 promoter; miR-19a overexpression and knockdown; cell invasion assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and functional epistasis with inducible system; single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"26804172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"APC regulates both actin and microtubule cytoskeletons to control cell migration; APC can stimulate Arp2/3 complex-dependent branched actin nucleation at the leading edge via microtubule-mediated signaling intermediates including interactions with IQGAP1 and other binding partners.\",\n      \"method\": \"Review synthesizing experimental data from multiple studies including co-localization, pulldowns, and functional migration assays with APC mutants\",\n      \"journal\": \"European journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — review article synthesizing prior primary experimental data; mechanistic model supported by multiple labs\",\n      \"pmids\": [\"35483122\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"APC is a multifunctional tumor suppressor that forms a destruction complex with axin and GSK3β to phosphorylate and target beta-catenin for ubiquitin-mediated degradation, thereby antagonizing Wnt signaling; it also directly binds EB1 and localizes to microtubule plus-ends to regulate mitotic spindle fidelity and directed cell migration, interacts with nuclear pore proteins and shuttles between nucleus and cytoplasm to suppress nuclear beta-catenin transcriptional activity, regulates DNA base excision repair via interaction with Pol-beta and Fen-1, and its mRNA stability is regulated by METTL3-mediated m6A modification and YTHDF-dependent degradation, with Myc acting as the critical downstream effector of neoplasia following APC loss.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify papers, then extract discoveries from KEEP papers only.\n\n**CLASSIFICATION:**\n- Papers about APC tumor suppressor (adenomatous polyposis coli): KEEP\n- Papers about APC/C (anaphase-promoting complex/cyclosome): EXCLUDE (different protein — E3 ubiquitin ligase complex)\n- Papers about APC as \"antigen-presenting cell\": EXCLUDE (alias collision)\n- Papers about DP2/CRTH2 prostaglandin receptor: EXCLUDE (alias collision)\n- Papers about APC superfamily transporters: EXCLUDE (alias collision)\n- Papers about HLA-DP molecules: EXCLUDE (alias collision)\n\n**KEPT papers:** 1, 2, 3, 4, 5, 6, 8, 9, 10, 13, 15, 17, 20, 23, 24, 36, 37, 40, 42, 44, 47, 53, 57, 59, 63, 64, 66, 69, 71, 74, 78, 81, 83, 90, 92, 93, 97, 99, 100\nAdditional curated: 2, 3, 5, 6, 10, 11, 13, 19, 20, 21, 22, 25, 26, 27, 28, 29, 30\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"The APC gene was identified at chromosome 5q21, found to be mutated in familial adenomatous polyposis (FAP) patients and in sporadic colorectal cancer; the gene encodes an unusually large protein predicted to contain coiled-coil regions.\",\n      \"method\": \"Positional cloning, SSCP mutation analysis, DNA sequencing\",\n      \"journal\": \"Cell / Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational cloning papers replicated across multiple independent labs simultaneously\",\n      \"pmids\": [\"1651174\", \"1651562\", \"1651563\", \"1678319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Somatic mutations in APC in colorectal tumors cluster within a small region of exon 15 (mutation cluster region, MCR), and >95% result in truncation of the APC protein; over 80% of colorectal tumors carry at least one APC mutation.\",\n      \"method\": \"DNA sequencing of tumor samples, LOH analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — large series of tumors with direct sequencing, replicated across labs\",\n      \"pmids\": [\"1338904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"APC protein associates with beta-catenin (a 95 kDa protein that binds E-cadherin) in cells, as demonstrated by co-immunoprecipitation with APC antibodies, suggesting APC is involved in cell adhesion.\",\n      \"method\": \"Co-immunoprecipitation, protein purification, peptide sequencing\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — reciprocal co-IP, protein identification by sequencing, replicated in same issue by independent lab\",\n      \"pmids\": [\"8259518\", \"8259519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"APC associates with both alpha-catenin and beta-catenin via a 27-residue fragment containing a 15-amino acid repeat of APC, revealing a direct structural link between APC, the catenins, and cell adhesion machinery.\",\n      \"method\": \"Co-immunoprecipitation, peptide mapping, nucleotide sequence analysis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — minimal binding domain mapped, replicated across two simultaneous independent studies\",\n      \"pmids\": [\"8259519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Full-length APC (~300 kDa) is expressed in normal cells, whereas colorectal tumor cells predominantly express truncated APC proteins lacking the C-terminus; APC localizes to the cytoplasm with more intense basolateral staining in the upper portions of colonic crypts, suggesting increased expression with cell maturation.\",\n      \"method\": \"Western blot with monoclonal/polyclonal antibodies, immunohistochemistry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct protein detection across 40+ cell lines with antibody panel, functional implication of localization\",\n      \"pmids\": [\"8385345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"E-cadherin and APC directly compete for binding to the internal armadillo-like repeats of beta-catenin; the NH2-terminal domain of beta-catenin then mediates cytoskeletal interaction via alpha-catenin, establishing that APC forms cell-junction-like complexes and that beta-catenin is a central regulator of both adhesion and tumor suppression.\",\n      \"method\": \"In vitro binding assays, co-immunoprecipitation, competition experiments\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct competition binding assay with purified proteins, mechanistic mapping of binding domains\",\n      \"pmids\": [\"7806582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"APC binds to the novel protein EB1 (a 268-amino acid protein with yeast homolog) through the carboxyl terminus of APC, as confirmed by two-hybrid screening, in vitro binding assays, and co-immunoprecipitation with anti-EB1 antibodies in vivo.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding assay, co-immunoprecipitation\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — interaction confirmed by three orthogonal methods including in vivo co-IP\",\n      \"pmids\": [\"7606712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"APC binds to GSK3beta when beta-catenin is present in excess; APC is a substrate for GSK3beta in vitro and phosphorylation sites were mapped to the central region of APC; phosphorylation by GSK3beta of this central region is required for beta-catenin binding to that region, establishing APC as part of the beta-catenin destruction complex.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, phosphorylation site mapping\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with phosphorylation site mapping, reciprocal interactions confirmed\",\n      \"pmids\": [\"8638126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Inducible expression of APC in colorectal cancer cells containing only inactive endogenous APC alleles causes substantial reduction in cell growth through induction of apoptosis, establishing a direct tumor-suppressive function for APC via programmed cell death.\",\n      \"method\": \"Inducible expression system, cell growth assay, apoptosis assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct functional rescue with defined cellular phenotype (apoptosis induction)\",\n      \"pmids\": [\"8755583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Human Axin binds directly to beta-catenin, GSK3beta, and APC in vitro; endogenous proteins form a complex in cells; Axin binding sites on APC map to a region deleted in cancer; Axin acts as a scaffold to coordinate APC, beta-catenin and GSK3beta, and dramatically facilitates GSK3beta-dependent phosphorylation of APC and beta-catenin.\",\n      \"method\": \"In vitro binding assays, co-immunoprecipitation from cells, overexpression/phosphorylation assays\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted complex with multiple proteins, phosphorylation assay in vitro and in vivo\",\n      \"pmids\": [\"9601641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Axin forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin; APC is integral to this complex through direct interaction with Axin's APC-binding domain.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding assay, co-immunoprecipitation, in vitro kinase assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted ternary complex and kinase assay, replicated\",\n      \"pmids\": [\"9482734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Beta-TrCP F-box protein binds directly to phosphorylated beta-catenin (phosphorylated at GSK3beta sites) and is a component of an E3 ubiquitin ligase responsible for targeted degradation of beta-catenin downstream of the APC/Axin/GSK3beta complex.\",\n      \"method\": \"Co-immunoprecipitation, direct binding assay, overexpression/dominant-negative experiments\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — direct binding mapped to phosphorylation sites, functional degradation assay\",\n      \"pmids\": [\"10074433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"APC protein moves along microtubules and concentrates as granules at their growing plus-ends in epithelial cells during cell spreading and wound healing; when MTs shorten, APC granules drop off the ends; the COOH-terminal region targets APC to growing MT ends, while the region lacking COOH-terminus forms granules that move along MTs in an ATP-dependent manner.\",\n      \"method\": \"GFP-fusion live cell imaging, deletion mutant analysis, immunoelectron microscopy\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — live imaging of full-length and deletion mutants in epithelial cells with ultrastructural confirmation\",\n      \"pmids\": [\"10662776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Crystal structure of the beta-catenin arm repeat domain in complex with E-cadherin cytoplasmic domain reveals that APC contains sequences homologous to the phosphorylated region of E-cadherin, suggesting APC competes with E-cadherin for an overlapping binding surface on beta-catenin in a phosphorylation-dependent manner.\",\n      \"method\": \"X-ray crystallography with functional mutant validation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — atomic structure with mechanistic interpretation validated by sequence homology analysis\",\n      \"pmids\": [\"11348595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CKIalpha (casein kinase Ialpha) is an Axin-associated kinase that phosphorylates beta-catenin at Ser45 as a priming event required for subsequent GSK-3beta phosphorylation; this dual-kinase mechanism within the APC/Axin destruction complex initiates the beta-catenin phosphorylation-degradation cascade, and Wnt signaling suppresses the CKIalpha priming step.\",\n      \"method\": \"In vitro kinase assay, mass spectrometry, phospho-specific antibodies, depletion experiments in Xenopus embryos\",\n      \"journal\": \"Cell / Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with identified kinase, phosphorylation site mapping by MS, in vivo validation\",\n      \"pmids\": [\"11955436\", \"12000790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"APC protein shuttles between multiple subcellular destinations including the cytoplasm, plasma membrane, microtubule plus-ends at the cell leading edge, and the nucleus, with each localization linked to distinct cellular functions including Wnt signaling regulation, cell migration, and chromosome stability.\",\n      \"method\": \"Immunofluorescence, GFP-tagging, fractionation studies (review of multiple experimental papers)\",\n      \"journal\": \"Nature reviews. Molecular cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — synthesis of multiple direct localization experiments with functional consequences\",\n      \"pmids\": [\"11988767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Simultaneous deletion of both Apc and Myc in the adult murine small intestine rescues the perturbed differentiation, migration, proliferation and apoptosis phenotypes caused by Apc loss alone, despite high nuclear beta-catenin levels; Myc is required for the majority of Wnt target gene activation following Apc loss, establishing Myc as the critical downstream mediator of early Apc-loss-driven neoplasia.\",\n      \"method\": \"Conditional double-knockout mouse model (in vivo deletion), array analysis, histological and cell biological phenotyping\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — genetic epistasis by double conditional knockout with multiple orthogonal readouts\",\n      \"pmids\": [\"17377531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BubR1 kinetochore kinase interacts with APC and EB1 in Xenopus egg extracts; BubR1 directly phosphorylates APC in vitro and forms a ternary complex with APC and microtubules; immunodepletion shows BubR1 kinase activity is essential for chromosome positioning at the metaphase plate, and this requires APC/EB1 complex formation for stable kinetochore-microtubule attachment.\",\n      \"method\": \"Xenopus egg extract immunodepletion, antibody addition, purified component reconstitution, in vitro kinase assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted ternary complex with purified proteins plus functional epistasis by depletion\",\n      \"pmids\": [\"17709426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Prostate-specific deletion of Apc in mice causes fully penetrant prostate hyperplasia and adenocarcinoma associated with elevated beta-catenin protein levels and high proliferation, demonstrating that APC loss-mediated Wnt/beta-catenin activation is sufficient to drive prostate carcinogenesis.\",\n      \"method\": \"Conditional Cre-mediated knockout (probasin-Cre), histopathology, immunohistochemistry\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — fully penetrant in vivo model with molecular pathway confirmation\",\n      \"pmids\": [\"17363566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"APC interacts with nuclear pore complex protein Nup153 (nucleoporin 153) through its middle region, and this interaction promotes association of microtubules with the nuclear membrane; this function is required for polarization of the microtubule cytoskeleton during directional cell migration.\",\n      \"method\": \"Co-immunoprecipitation, GFP-localization, dominant-negative expression, scratch-wound migration assay\",\n      \"journal\": \"Biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — co-IP of endogenous proteins plus functional migration assay, single lab\",\n      \"pmids\": [\"18042042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"APC regulates DNA base excision repair (BER) through interaction with DNA polymerase beta (Pol-beta) and flap endonuclease 1 (Fen-1), and APC gene transcription is activated by alkylating agents, suggesting APC modulates whether DNA-damaged cells survive or undergo apoptosis.\",\n      \"method\": \"Interaction assays, BER activity measurement, transcriptional induction assays (review synthesizing experimental data)\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — multiple interaction studies from single group, no structural validation\",\n      \"pmids\": [\"18662849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"APC associates with mitotic spindle microtubules at their plus-ends at kinetochores; genetic and functional experiments show APC regulates spindle microtubule dynamics through EB1 interaction; APC is required for the spindle checkpoint to detect transiently misaligned chromosomes; truncated APC alleles act dominantly to inhibit the mitotic spindle, placing chromosome instability at the earliest stage of colorectal cancer.\",\n      \"method\": \"Immunofluorescence, genetic epistasis in yeast and mammalian cells, dominant-negative expression, spindle checkpoint assays\",\n      \"journal\": \"Advances in experimental medicine and biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (localization, genetics, functional checkpoint assay) in multiple systems\",\n      \"pmids\": [\"19928352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nup358 (RanBP2) interacts with the middle region of APC (a region with microtubule plus-end-targeting activity), cooperates with kinesin-2 in a nuclear-transport-independent mechanism to regulate APC localization to the cell cortex, and is required for polarized cell migration as shown by RNAi knockdown in wound-healing assays.\",\n      \"method\": \"Co-immunoprecipitation, ectopic expression, RNAi knockdown, scratch-wound migration assay, MT plus-end tracking\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interactions plus functional RNAi phenotype, single lab\",\n      \"pmids\": [\"19654215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nuclear APC contains two classical nuclear localization signals and nuclear export signals enabling shuttling between nucleus and cytoplasm; nuclear APC opposes beta-catenin-mediated transcription through nuclear sequestration of beta-catenin and interaction with transcriptional corepressor CtBP; additional nuclear partners include AP-2alpha, Crm1, PTP-BL, DNA polymerase beta, and PCNA.\",\n      \"method\": \"NLS/NES mapping, nuclear import/export assays, co-immunoprecipitation, transcription reporter assays\",\n      \"journal\": \"Advances in experimental medicine and biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods defining nuclear trafficking signals and functional transcriptional repression\",\n      \"pmids\": [\"19928349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Microflora-MyD88-ERK signaling in intestinal epithelial cells promotes tumorigenesis in Apc(min/+) mice by phosphorylating c-Myc to prevent its ubiquitination and proteasomal degradation; Apc(min/+)/Myd88(-/-) mice have lower p-ERK and fewer/smaller tumors; ERK inhibitor suppresses tumorigenesis, establishing a microflora-TLR-ERK-Myc axis downstream of Apc loss.\",\n      \"method\": \"Genetic epistasis (double knockout), biochemical phosphorylation assay, pharmacological inhibition, in vivo tumor analysis\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological epistasis with defined molecular mechanism\",\n      \"pmids\": [\"20473309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Wnt signaling does not disassemble the APC/Axin1 destruction complex nor inhibit phosphorylation of Axin1-bound beta-catenin; instead, Wnt suppresses beta-catenin ubiquitination within an intact complex, leading to complex saturation by phospho-beta-catenin, so that newly synthesized beta-catenin accumulates in free cytosolic form and engages nuclear TCF factors.\",\n      \"method\": \"Endogenous protein immunoprecipitation, phosphorylation assays, ubiquitination assays, proteasome inhibition, intestinal organoids\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mechanistic dissection of destruction complex at endogenous levels in multiple cell systems including primary intestinal epithelium\",\n      \"pmids\": [\"22682247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"APC regulates the miR-17-92 cluster through the beta-catenin pathway: activated beta-catenin resulting from APC loss binds to and activates the miR-17-92 promoter; enforced expression of miR-19a overrides APC tumor suppressor activity, and knockdown of miR-19a reduces aggressive features in cells with compromised APC.\",\n      \"method\": \"APC-inducible cell line, miRNA array, ChIP, promoter reporter assay, miRNA overexpression/knockdown\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ChIP, reporter, functional rescue) from single lab\",\n      \"pmids\": [\"26804172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Phosphorylated beta-catenin preferentially binds to the 15 amino acid repeats (15R) of APC rather than the first 20 amino acid repeat, suggesting the 15R region constitutes a gate connecting beta-catenin phosphorylation and subsequent ubiquitination/degradation; truncated APC in colorectal tumors almost always retains at least one 15R, and APCL (APC2 paralog) uses the 15R of truncated APC via heterodimerization to target beta-catenin for degradation.\",\n      \"method\": \"RNA interference, domain-swap experiments, co-immunoprecipitation, beta-catenin degradation assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (RNAi, domain swaps, co-IP) defining mechanistic step, single lab\",\n      \"pmids\": [\"23840886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"METTL3 upregulates m6A modification of APC mRNA, which recruits YTHDF protein to promote APC mRNA degradation; reduced APC expression then increases beta-catenin and downstream targets (cyclin D1, c-Myc, PKM2), promoting aerobic glycolysis and tumor formation in esophageal squamous cell carcinoma.\",\n      \"method\": \"m6A-RIP sequencing, RNA immunoprecipitation, METTL3 knockdown/overexpression, YTHDF binding assay, xenograft mouse model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — m6A-RIP-seq, direct YTHDF binding, functional rescue in vivo, multiple orthogonal methods\",\n      \"pmids\": [\"34155197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The kinesin motor KIF1C interacts with APC-dependent mRNAs and is required for their transport to cytoplasmic protrusions; live two-color imaging directly shows single mRNAs transported by single KIF1C motors; the 3'UTR of APC-dependent mRNAs is sufficient to trigger KIF1C-dependent transport, and KIF1C also clusters these mRNAs at the periphery.\",\n      \"method\": \"RNA immunoprecipitation, live single-molecule imaging (two-color), siRNA knockdown, 3'UTR sufficiency assay\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — direct single-molecule visualization of transport plus mechanistic dissection of 3'UTR requirement\",\n      \"pmids\": [\"34493599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"APC regulates both actin and microtubule cytoskeletons during cell migration; APC at microtubule plus-ends can stimulate Arp2/3 complex-dependent nucleation of branched actin filament networks via intermediate signaling events, linking microtubule dynamics to leading-edge protrusion through APC as an intermediate.\",\n      \"method\": \"Live-cell imaging, FRAP, actin nucleation assays, loss-of-function experiments (review integrating experimental data)\",\n      \"journal\": \"European journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — synthesis of multiple experimental approaches from multiple labs, mechanistic model supported by functional data\",\n      \"pmids\": [\"35483122\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"APC is a multifunctional tumor suppressor that acts as a scaffold in the beta-catenin destruction complex (with Axin, CKIalpha, and GSK3beta) to promote sequential phosphorylation and ubiquitin-proteasome-dependent degradation of beta-catenin, thereby suppressing Wnt/TCF target gene transcription including c-Myc; APC additionally localizes to microtubule plus-ends (via EB1 interaction and KIF1C-dependent transport), the nuclear membrane (via Nup358), and the nucleus (where it represses beta-catenin transcription via CtBP and participates in DNA repair via Pol-beta and Fen-1), and contributes to chromosomal stability through kinetochore-microtubule attachment regulation and the spindle checkpoint.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"APC is a multifunctional tumor suppressor that serves as a central node integrating Wnt/beta-catenin signaling, cytoskeletal dynamics, and genome maintenance in epithelial homeostasis. APC physically associates with beta-catenin and, through its 15-amino-acid repeat domain, gates the transition from beta-catenin phosphorylation to ubiquitin-mediated degradation; loss of APC stabilizes beta-catenin, which activates Myc as the critical downstream effector of intestinal neoplasia [PMID:8259518, PMID:23840886, PMID:17377531]. APC localizes to microtubule plus-ends via its C-terminal EB1-binding domain, interacts with nucleoporins Nup153 and Nup358 to link microtubules to the nuclear envelope, and coordinates actin and microtubule networks to direct polarized cell migration and mitotic spindle fidelity [PMID:10662776, PMID:7606712, PMID:18042042, PMID:17709426]. APC also shuttles between nucleus and cytoplasm to suppress beta-catenin-mediated transcription, participates in base excision repair through interactions with Pol-beta and Fen-1, and its mRNA is subject to METTL3/YTHDF-dependent m6A-mediated degradation that modulates pathway output [PMID:19928349, PMID:18662849, PMID:34155197].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"The discovery that APC physically binds beta-catenin established the first molecular link between the APC tumor suppressor and cell adhesion/signaling, reframing APC from a gene defined solely by mutational genetics to a biochemically tractable signaling regulator.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation from mammalian cell lysates with protein identification by sequencing\",\n      \"pmids\": [\"8259518\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether APC binding leads to beta-catenin degradation or merely sequestration was unknown\",\n        \"No in vitro reconstitution of a destruction complex\",\n        \"Functional consequence for Wnt target gene transcription not tested\"\n      ]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Demonstrating that full-length APC is cytoplasmic and enriched in differentiating colonic epithelium, while tumors express only truncated forms, linked APC protein expression to the differentiation program that is disrupted in colorectal cancer.\",\n      \"evidence\": \"Western blot with APC-specific antibodies and immunohistochemistry of normal colonic mucosa and tumor cell lines\",\n      \"pmids\": [\"8385345\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether APC drives differentiation or is merely upregulated during it was unclear\",\n        \"Truncated protein functionality not assessed\"\n      ]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identification of EB1 as a direct APC-binding partner at its C-terminus revealed that APC connects to the microtubule plus-end tracking machinery, opening the question of how APC coordinates signaling with cytoskeletal regulation.\",\n      \"evidence\": \"Yeast two-hybrid screen, in vitro binding assay, and co-immunoprecipitation in mammalian cells\",\n      \"pmids\": [\"7606712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the APC–EB1 interaction is functionally relevant for mitosis or migration was untested\",\n        \"No live-cell visualization of APC at microtubule tips\"\n      ]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Showing that re-expression of wild-type APC in APC-null colorectal cancer cells induces apoptosis established APC as a functional regulator of programmed cell death, not merely a proliferation brake.\",\n      \"evidence\": \"Inducible APC expression in APC-null colorectal cancer cell lines with cell growth and apoptosis assays\",\n      \"pmids\": [\"8755583\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether apoptosis is mediated through beta-catenin suppression or an independent pathway was not resolved\",\n        \"In vivo validation lacking at this stage\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Live imaging revealed that APC moves along microtubules and accumulates at growing plus-ends via its C-terminal domain, providing the first dynamic visualization of APC's cytoskeletal behavior and showing that truncating mutations remove this function.\",\n      \"evidence\": \"GFP-tagged full-length and deletion mutants of Xenopus APC imaged live in epithelial cells; immunoelectron microscopy\",\n      \"pmids\": [\"10662776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Motor identity responsible for APC transport was not identified\",\n        \"Whether plus-end localization is required for tumor suppression was unclear\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genetic epistasis showed that Myc is the critical downstream effector of Apc loss in the intestine: simultaneous deletion of Myc fully rescued the proliferation, migration, differentiation, and apoptosis defects caused by Apc deletion, resolving which Wnt target gene drives early neoplasia.\",\n      \"evidence\": \"Simultaneous conditional deletion of Apc and Myc in adult murine small intestine (Cre-lox) with histology and transcriptomic analysis\",\n      \"pmids\": [\"17377531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Myc is equally critical in colonic versus small intestinal tumorigenesis was not tested\",\n        \"Contribution of other Wnt targets in later tumor progression remained open\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that BubR1 phosphorylates APC and forms a ternary complex with APC–EB1–microtubules provided a mechanistic basis for APC's role in mitotic chromosome alignment and spindle checkpoint function.\",\n      \"evidence\": \"In vitro kinase assay with purified BubR1, immunodepletion from Xenopus egg extracts, co-immunoprecipitation\",\n      \"pmids\": [\"17709426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific phosphorylation sites on APC and their individual contributions were not mapped\",\n        \"Relevance to chromosomal instability in APC-mutant tumors not directly tested\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"APC was shown to interact with nucleoporins Nup153 and to shuttle between nucleus and cytoplasm, establishing dual mechanisms — nuclear beta-catenin sequestration via CtBP interaction and microtubule–nuclear envelope tethering — by which APC coordinates signaling suppression with cytoskeletal polarization during migration.\",\n      \"evidence\": \"Co-immunoprecipitation of APC with Nup153; NLS/NES mapping; reporter assays for beta-catenin transcription; scratch-wound migration assays\",\n      \"pmids\": [\"18042042\", \"19928349\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural basis of APC–nucleoporin interaction is unknown\",\n        \"Relative contribution of nuclear versus cytoplasmic APC pools to tumor suppression not quantified\",\n        \"Single-lab findings for Nup153 interaction\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery that APC interacts with DNA polymerase-beta and Fen-1 and modulates base excision repair revealed a signaling-independent mechanism by which APC loss could promote genomic instability.\",\n      \"evidence\": \"Co-immunoprecipitation/pulldown of APC with Pol-beta and Fen-1; in vitro BER activity assays\",\n      \"pmids\": [\"18662849\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether BER deficiency contributes meaningfully to APC-mutant tumor mutation burden in vivo is untested\",\n        \"Single-lab observation; independent replication needed\",\n        \"No structural detail of APC–Pol-beta interface\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Mapping the 15-amino-acid repeat region of APC as the gate linking beta-catenin phosphorylation to ubiquitination clarified why colorectal cancers retain truncated APC with some 20-amino-acid repeats: the 15R domain is specifically required for degradation handoff.\",\n      \"evidence\": \"Co-immunoprecipitation, domain-swapping, RNAi, and beta-catenin degradation assays in colon cancer cell lines\",\n      \"pmids\": [\"23840886\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural or biophysical characterization of phospho-beta-catenin binding to 15R\",\n        \"Whether APCL heterodimerization occurs at physiological expression levels is unclear\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of METTL3-mediated m6A modification on APC mRNA as a mechanism for APC post-transcriptional silencing revealed an epitranscriptomic layer of Wnt pathway regulation, with YTHDF readers directing APC mRNA degradation to stabilize beta-catenin.\",\n      \"evidence\": \"m6A-RIP-seq, METTL3 overexpression/knockdown, YTHDF RIP, luciferase reporters, xenograft tumor formation\",\n      \"pmids\": [\"34155197\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific m6A sites on APC mRNA that are functionally critical were not individually mutated\",\n        \"Whether this mechanism operates in normal intestinal stem cells is unknown\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Single-molecule imaging showed that the kinesin KIF1C transports APC-dependent mRNAs along microtubules to cell protrusions via 3ʹUTR-dependent recognition, establishing a molecular motor mechanism for APC mRNA localization.\",\n      \"evidence\": \"Two-color live single-molecule RNA imaging, KIF1C knockdown, 3ʹUTR reporter constructs\",\n      \"pmids\": [\"34493599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether KIF1C-mediated APC mRNA transport affects local APC protein levels and Wnt signaling output is untested\",\n        \"Adapter proteins linking KIF1C to the APC mRNA 3ʹUTR are not identified\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A comprehensive structural understanding of the full-length APC destruction complex — including how APC integrates its beta-catenin degradation, cytoskeletal, DNA repair, and nucleocytoplasmic shuttling functions — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of full-length APC or of the complete APC–axin–GSK3β–beta-catenin destruction complex\",\n        \"Relative contributions of APC's cytoskeletal versus signaling functions to tumor suppression in vivo are not disentangled\",\n        \"Whether APC BER function is clinically relevant in colorectal cancer mutational landscapes is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3, 5, 8, 13]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [2, 4, 6, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [4, 6, 15]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [9, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 5, 8, 13, 14]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 11, 14]}\n    ],\n    \"complexes\": [\n      \"beta-catenin destruction complex\",\n      \"APC-EB1-BubR1 complex\"\n    ],\n    \"partners\": [\n      \"CTNNB1\",\n      \"MAPRE1\",\n      \"BUB1B\",\n      \"NUP153\",\n      \"RANBP2\",\n      \"CTBP1\",\n      \"POLB\",\n      \"FEN1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"APC is a multifunctional tumor suppressor that serves as the central scaffold of the β-catenin destruction complex, recruiting Axin, GSK-3β, and CKIα to drive sequential phosphorylation of β-catenin at Ser45 (CKIα priming) and subsequent GSK-3β sites, thereby licensing β-TrCP-mediated ubiquitination and proteasomal degradation of β-catenin and suppressing Wnt/TCF target gene transcription—most critically c-Myc, which is the essential downstream effector of APC-loss-driven intestinal neoplasia [PMID:9601641, PMID:11955436, PMID:22682247, PMID:17377531]. Germline truncating mutations in APC cause familial adenomatous polyposis (FAP), and somatic APC truncations—clustered in the mutation cluster region of exon 15—are found in >80% of sporadic colorectal cancers [PMID:1651174, PMID:1338904]. Beyond Wnt regulation, APC localizes to microtubule plus-ends via its C-terminal EB1-binding domain, contributes to kinetochore–microtubule attachment and the spindle assembly checkpoint through a BubR1–EB1 ternary complex, and coordinates actin-based protrusion during polarized cell migration [PMID:10662776, PMID:17709426, PMID:19928352, PMID:35483122]. APC also shuttles into the nucleus where it represses β-catenin/TCF transcription via CtBP interaction and participates in DNA base excision repair through associations with DNA polymerase β and Fen-1 [PMID:19928349, PMID:18662849].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Positional cloning of the APC gene at 5q21 and identification of truncating germline mutations in FAP patients established APC as the causal tumor suppressor for hereditary colorectal polyposis.\",\n      \"evidence\": \"Positional cloning and SSCP/DNA sequencing in FAP kindreds and sporadic colorectal cancers\",\n      \"pmids\": [\"1651174\", \"1651562\", \"1651563\", \"1678319\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protein function was unknown at the time of cloning\", \"Mechanism linking APC loss to tumorigenesis was entirely undefined\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Discovery that APC directly binds β-catenin through 15-amino-acid repeats provided the first molecular link between APC and the cell adhesion/signaling machinery, reframing APC as a regulator of catenin biology rather than a conventional growth-factor pathway component.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation and peptide mapping in epithelial cell lines\",\n      \"pmids\": [\"8259518\", \"8259519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether APC regulated β-catenin levels or only its adhesive function was unresolved\", \"Kinase and ubiquitin-ligase components of the pathway were unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identification of EB1 as an APC C-terminal binding partner revealed a second functional axis—microtubule plus-end association—distinct from the β-catenin regulatory role.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding, and co-immunoprecipitation\",\n      \"pmids\": [\"7606712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of APC–EB1 interaction for cell division was undefined\", \"Whether the C-terminus was relevant to tumor suppression remained unclear\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Demonstration that GSK-3β phosphorylates APC and that this phosphorylation is required for high-affinity β-catenin binding established the enzymatic logic of the destruction complex—kinase activity modulates the scaffold's ability to capture its substrate.\",\n      \"evidence\": \"In vitro kinase assay, phosphorylation site mapping, co-immunoprecipitation\",\n      \"pmids\": [\"8638126\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The scaffold protein Axin had not yet been placed in the complex\", \"Priming kinase upstream of GSK-3β was unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of Axin as the central scaffold that directly binds APC, β-catenin, and GSK-3β, and dramatically enhances GSK-3β-dependent phosphorylation, completed the core architecture of the destruction complex.\",\n      \"evidence\": \"Reconstituted quaternary complex with purified components, co-immunoprecipitation from cells, in vitro kinase assays\",\n      \"pmids\": [\"9601641\", \"9482734\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Priming phosphorylation step was still missing\", \"Ubiquitin-ligase link to proteasomal degradation was not yet defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of CKIα as the priming kinase that phosphorylates β-catenin at Ser45 within the Axin-bound complex, prerequisite for GSK-3β processivity, completed the dual-kinase phosphorylation cascade and explained how Wnt signaling blocks the initial trigger of β-catenin degradation.\",\n      \"evidence\": \"In vitro kinase assay, mass spectrometry, phospho-specific antibodies, Xenopus embryo depletion\",\n      \"pmids\": [\"11955436\", \"12000790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Wnt signaling mechanistically inhibits destruction complex output was still debated\", \"Structural basis for CKIα priming within the complex was unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genetic epistasis showing that simultaneous Myc deletion rescues the proliferative and differentiation defects of Apc loss in intestinal epithelium established c-Myc as the critical transcriptional effector of Wnt pathway activation downstream of APC, defining the key oncogenic output of APC mutations.\",\n      \"evidence\": \"Conditional double-knockout mouse model with histological and transcriptomic phenotyping\",\n      \"pmids\": [\"17377531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Myc dependence extends to late-stage carcinomas was untested\", \"Additional Wnt targets contributing to full malignant progression were not excluded\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Reconstitution of a BubR1–APC–EB1 ternary complex and demonstration that BubR1 phosphorylates APC to regulate kinetochore–microtubule attachments established a mitotic function for APC separate from Wnt signaling, linking APC truncation to chromosomal instability.\",\n      \"evidence\": \"Xenopus egg extract immunodepletion, in vitro kinase assay, purified ternary complex\",\n      \"pmids\": [\"17709426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of chromosomal instability versus Wnt activation to tumorigenesis was unresolved\", \"APC phosphorylation sites by BubR1 and their structural consequences were not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstration that Wnt signaling does not disassemble the destruction complex but instead suppresses β-catenin ubiquitination within an intact complex—causing its saturation and accumulation of free cytosolic β-catenin—fundamentally revised the model of how APC/Axin regulate β-catenin flux.\",\n      \"evidence\": \"Endogenous immunoprecipitation, phosphorylation and ubiquitination assays, proteasome inhibition, intestinal organoids\",\n      \"pmids\": [\"22682247\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which Wnt inhibits the ubiquitination step within the intact complex remains structurally unresolved\", \"Whether saturation model applies equivalently across all tissue types is untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Single-molecule imaging revealed KIF1C-dependent transport of APC-associated mRNAs to cytoplasmic protrusions via 3′UTR-encoded signals, establishing a post-transcriptional logistics role for APC in polarized mRNA localization beyond its canonical protein-level functions.\",\n      \"evidence\": \"Live two-color single-molecule imaging, RNA immunoprecipitation, siRNA knockdown, 3′UTR sufficiency assay\",\n      \"pmids\": [\"34493599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether APC protein itself directly contacts the mRNA or acts through adaptor proteins is unclear\", \"Functional consequences of mRNA mislocalization in APC-mutant tumors are not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structural model of the full destruction complex—showing how APC, Axin, CKIα, GSK-3β, and β-TrCP coordinate β-catenin capture, processivity of dual phosphorylation, and handoff to the ubiquitin ligase—remains unavailable, limiting mechanistic understanding of how specific APC truncations differentially affect complex activity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length APC structure exists\", \"How APC truncation positions (MCR variations) quantitatively alter destruction complex output is undefined\", \"Relative contributions of chromosomal instability, Wnt deregulation, and BER deficiency to APC-driven tumorigenesis are not quantitatively partitioned\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [9, 10, 14, 25]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [6, 12, 17, 21, 30]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 11, 25, 27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 15, 25]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [12, 17, 21, 30]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [15, 23]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 15, 22]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [17, 21]},\n      {\"term_id\": \"GO:0005635\", \"supporting_discovery_ids\": [19, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 7, 9, 10, 14, 25]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [17, 21]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 1, 16, 18]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [11, 14, 25]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"complexes\": [\n      \"β-catenin destruction complex (APC/Axin/GSK-3β/CKIα)\",\n      \"APC–EB1–BubR1 kinetochore complex\"\n    ],\n    \"partners\": [\n      \"CTNNB1\",\n      \"AXIN1\",\n      \"GSK3B\",\n      \"CSNK1A1\",\n      \"MAPRE1\",\n      \"BUBR1\",\n      \"CTBP1\",\n      \"NUP358\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}